{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:03:40Z","timestamp":1787166220466,"version":"build-2736575974"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background\/aims<\/jats:title>\n                    <jats:p>The aim was to explore the impact of sex on prevalence, patterns and trends in the prescription of psychotropics and analgesics in users of acetylcholinesterase inhibitors (AChEIs), before and after AChEI initiation, compared to the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective study applying data from the Norwegian Prescription Database (NorPD) in the period 2004\u20132016. Prescription of antidepressants, antipsychotics, analgesics including opioids, benzodiazepines and z-hypnotics in persistent AChEI users was studied in a follow-up period from four years before to two years after AChEI initiation in men and women of four age groups: 37\u201364, 65\u201372, 73\u201380 and 81\u201388 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Use of antidepressants, antipsychotics and weaker analgesics increased in both sexes during the follow-up period in 11.764 persistent AChEI users. Women with pre-dementia and dementia stages of AD showed a prescription pattern with more use of psychotropics and opioids than men, except for antipsychotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Female sex showed to have a significant influence on the prescriptions of psychotropics and analgesics in AD patients in a pre-dementia and dementia stage. The exception is for antipsychotics, that men used more than women. The prescription pattern showed a higher extent of polypharmacy of psychotropics and\/or opioids in women than in men. The total prescription pattern of analgesics could indicate an undertreatment of pain in pre-dementia and dementia stages, most pronounced in men.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0243804","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T14:07:57Z","timestamp":1632146877000},"page":"e0243804","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6678-0300","authenticated-orcid":true,"given":"Anne Sverdrup","family":"Efjestad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Ihle-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar","family":"Hjellvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Engedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Salvesen Blix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"pone.0243804.ref001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eurpsy.2011.06.001","article-title":"Alzheimer\u00b4s disease and co-morbidity: Increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up.","volume":"28","author":"R Heun","year":"2013","journal-title":"Eur Psychiatry"},{"key":"pone.0243804.ref002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.phrs.2016.11.035","article-title":"Sex and gender differences in the treatment of Alzheimer\u00b4s disease: A systematic review of randomized trials","volume":"115","author":"M Canevelli","year":"2017","journal-title":"Pharmacol Res"},{"key":"pone.0243804.ref003","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jamda.2014.06.015","article-title":"Associated factors with antipsychotic use in long-term instututional care in eight european countries: Results from the RightTimePlacsCare Study.","volume":"15","author":"A de Mauleon","year":"2014","journal-title":"JJ Am Med Dir Assoc"},{"key":"pone.0243804.ref004","article-title":"Gender differences in presentation of behavioral and psychological symptoms in Alzheimer\u00b4s disease in Taiwan.","author":"S-W Hsieh","journal-title":"Aging Ment Health"},{"key":"pone.0243804.ref005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40266-016-0419-5","article-title":"A comparison of sex differences in psychotropic medication use in older people with alzheimer\u2019s disease in the US and Finland.","volume":"34","author":"DC Moga","year":"2017","journal-title":"Drugs Aging"},{"key":"pone.0243804.ref006","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1532-5415.2011.03654.x","article-title":"Concomitant Use of Cholinesterase Inhibitors and Anticholinergics: Prevalence and Outcomes.","volume":"59","author":"DM Boudreau","year":"2011","journal-title":"J Am Geriatr Soc."},{"key":"pone.0243804.ref007","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.psc.2011.02.004","article-title":"Epidemiology, assessment, and treatment of dementia.","volume":"34","author":"MA Nowrangi","year":"2011","journal-title":"Psychiatr Clin N Am"},{"key":"pone.0243804.ref008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psc.2017.10.010","article-title":"Managing behavioral and psychological symptoms of dementia.","volume":"41","author":"LB Gerlach","year":"2018","journal-title":"Psychiatr Clin N Am"},{"key":"pone.0243804.ref009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000454948","article-title":"Comedication and treatment length in users of acetylcholinesterase inhibitors.","volume":"7","author":"AS Efjestad","year":"2017","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"pone.0243804.ref010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000497307","article-title":"Drug use before and after initiating treatment with acetylcholinesterase inhibitors.","volume":"9","author":"AS Efjestad","year":"2019","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"pone.0243804.ref011","unstructured":"National professional guideline dementia [online]. The Norwegian Directorate of Health, Jan.03.2020, Available from: www.helsedirektoratet.no"},{"key":"pone.0243804.ref012","unstructured":"Dementia: assessment, management and support for people living with dementia and their carers [online]. nice.org.uk\/guidance\/ng97."},{"key":"pone.0243804.ref013","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","article-title":"Psychotropic drug use and psychotropic polypharmacy among persons with Alzheimer\u00b4s disease.","volume":"28","author":"K Orsel","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"pone.0243804.ref014","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1345\/aph.1M147","article-title":"Sex differences in inappropriate drug use: a register-based study of over 600.000 older people","volume":"43","author":"K Johnell","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"2","key":"pone.0243804.ref015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clinthera.2017.12.016","article-title":"Women and the experience of pain and opioid use disorder: a literature-based commentary","volume":"40","author":"AL Koons","year":"2018","journal-title":"Clinical Therapeutics"},{"key":"pone.0243804.ref016","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejim.2015.07.006","article-title":"Gender differences in hospitalized elderly patients.","volume":"26","author":"P Santalucia","year":"2015","journal-title":"Eur J of Int Med"},{"issue":"3","key":"pone.0243804.ref017","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S1041610209008497","article-title":"Sex differences in the prevalence of behavioral and psychological symptoms of dementia.","volume":"21","author":"H L\u00f6vheim","year":"2009","journal-title":"Int Psychogeriatr"},{"issue":"49","key":"pone.0243804.ref018","first-page":"1","article-title":"Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway.","volume":"19","author":"AF Fog","year":"2019","journal-title":"BMC Geriatr"},{"issue":"4","key":"pone.0243804.ref019","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/02813432.2017.1397246","article-title":"Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway.","volume":"35","author":"AF Fog","year":"2017","journal-title":"Scand J Prim Health Care"},{"key":"pone.0243804.ref020","unstructured":"ATC Classification Index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology. [online] 2017. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"pone.0243804.ref021","volume-title":"A language and environment for statistical computing","author":"R Core Team"},{"key":"pone.0243804.ref022","unstructured":"FOR-2003-10-17-1246. Regulations concerning the collection and processing of health data in the prescription database. [online] Available from: www.lovdata.no."},{"key":"pone.0243804.ref023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajp.2017.01.027","article-title":"Gender differences in behavioral and psychological symptoms of patients with Alzheimer\u00b4s disease.","volume":"26","author":"J Lee","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"pone.0243804.ref024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/pb.bp.116.054270","article-title":"Are men under-treated and women over-treated with antidepressants? Findings from a cross-sectional survey in Sweden.","volume":"41","author":"LT Sundbom","year":"2017","journal-title":"BJPsych Bull"},{"issue":"115","key":"pone.0243804.ref025","first-page":"1","article-title":"Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011.","volume":"16","author":"C Gulla","year":"2016","journal-title":"BMC Geriatr"},{"key":"pone.0243804.ref026","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00228-016-2145-7","article-title":"Characteristics and drug use patterns of older antidepressant initiators in Germany","volume":"73","author":"K Jobski","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0243804.ref027","unstructured":"Crediblemeds. List of drugs that prolong QT and\/or cause TDP. Available from: https:\/\/crediblemedsorg\/new-drug-list\/."},{"key":"pone.0243804.ref028","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cger.2018.06.009","article-title":"Behavioral Problems and dementia.","volume":"34","author":"L Volicer","year":"2018","journal-title":"Clin Geriatr Med."},{"key":"pone.0243804.ref029","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jad.2018.04.015","article-title":"The course of anxiety in persons with dementia in Norwegian nursing homes: A 12- month follow-up study","volume":"235","author":"AR Goyal","year":"2018","journal-title":"J Affect Disord"},{"key":"pone.0243804.ref030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13311-019-00801-9","article-title":"Benzodiazepines, z-hypnotics, and risk of dementia: special considerations of half-lives and concomitant use.","volume":"17","author":"L-Y Tseng","year":"2020","journal-title":"Neurtherapeutics."},{"issue":"9","key":"pone.0243804.ref031","doi-asserted-by":"crossref","first-page":"e0204413","DOI":"10.1371\/journal.pone.0204413","article-title":"Use of sedative-hypnotics and the risk of Alzheimer\u00b4s dementia: A retrospective cohort study.","volume":"13","author":"J Lee","year":"2018","journal-title":"PLoS One."},{"key":"pone.0243804.ref032","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pds.1827","article-title":"Gender differences in the use of anxiolytics and antidepressants: a population based study.","volume":"18","author":"JHA Van der Heyden","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0243804.ref033","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/IJWH.S142052","article-title":"Gender differences in dispensed analgesics in Sweden during 2006\u20132015\u2014an observational, nationwide, whole-population study.","volume":"10","author":"E B\u00e4ckryd","year":"2018","journal-title":"Int J Women\u00b4s Health."},{"key":"pone.0243804.ref034","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3233\/JAD-160828","article-title":"Psychotropic polypharmacy in patients with dementia: prevalence and predictors","volume":"56","author":"A N\u00f8rgaard","year":"2017","journal-title":"Journal of Alzheimer\u00b4s disease"},{"key":"pone.0243804.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050312119845715","article-title":"Sex and gender differences in polypharmacy in persons with dementia: A scoping review.","volume":"7","author":"SC Trenaman","year":"2019","journal-title":"SAGE Open Med"},{"key":"pone.0243804.ref036","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40266-019-00690-9","article-title":"Sex differences in the prevalent use of oral formulations of cholinesterase inhibitors in older adults with dementia.","volume":"36","author":"L Zhu","year":"2019","journal-title":"Drugs Aging"},{"key":"pone.0243804.ref037","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jns.2017.08.2902","article-title":"Mortality risk associated with psychotropic polypharmacy in patients with dementia","volume":"381","author":"A N\u00f8rgaard","year":"2017","journal-title":"J Neurol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T14:08:44Z","timestamp":1632146924000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243804"}},"subtitle":[],"editor":[{"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243804","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]}}}